Best Operation by doctor's recommendation diagnosticians in Turkey: TOP 25 doctors

AREAS OF INTEREST 

Radial Angiography

Complex coronary interventions 

Intracoronary examinations (FFR, IVUS, OCT) 

Calcific lesion treatments (Rotablator, shockwave balloon ) 

Chronic total occlusion attempts 

Transcatheter Aortic valve implantations (TAVI) 

Aortic interventions 

Mitral valve attempts 

Peripheral arterial interventions 

ASD/PFO/VSD closure 

LAA closure 

Paravalvuler closure 

Carotid arterial interventions 

Septal ablation 

Pulmonary embolism interventions

Education 

Cerrahpaşa Faculty of Medicine 

Istanbul University Institute of Cardiology 

Royal Brompton Hospital (London) 

Experience 

Istanbul University Institute of Cardiology 

Turkish Kidney Foundation Service Hospital 

Istanbul University Institute of Cardiology 

Royal Brompton Hospital

University of Health Sciences Şişli Hamidiye Etfal Hospital (founding chief)

University of Health Sciences Prof. Dr. Cemil Taşçıoğlu city hospital (founding chief) 

LIV Hospital Ulus

Memberships 

Turkish Society of Cardiology 

European Society of Cardiolog

• AREAS OF INTEREST
• Trauma surgery
• Arthroplasty
• Sports Injuries
• Ankle surgery
• Arthroscopic joint surgery

• Education and Training:
• Medical Degree: Graduated from Marmara University Faculty of Medicine, where he received comprehensive medical training.
• Specialization in Orthopedics and Traumatology: Completed his residency at Haseki Training and Research Hospital, gaining specialized expertise in orthopedics and traumatology.

• Professional Experience:
• Current Position: Serving as an Orthopedic and Traumatology Specialist at İstinye University Hospital Medical Park Gaziosmanpaşa, Istanbul. This institution is known for its innovative approach to healthcare, combining advanced technology with personalized patient care.
• Clinical Expertise: Dr. Şener has substantial experience in treating various orthopedic conditions, including meniscus tears, joint arthritis, sports injuries, and ankle surgery. He is also proficient in performing advanced surgical procedures such as arthroplasty and arthroscopic surgery.

• Areas of Expertise:
• Trauma Surgery: Skilled in managing and treating traumatic injuries, ensuring optimal recovery and rehabilitation for patients.
• Joint Replacement: Expert in performing joint replacement surgeries, providing relief to patients suffering from severe joint pain and arthritis.
• Sports Injuries: Specialized in diagnosing and treating sports-related injuries, helping athletes return to their peak performance.
• Arthroscopic Surgery: Proficient in minimally invasive arthroscopic procedures, reducing recovery time and improving outcomes for patients with joint issues.

• Competitive Advantages:
• Advanced Surgical Techniques: Utilizes cutting-edge surgical techniques and equipment, ensuring high precision and better patient outcomes.
• Multidisciplinary Approach: Collaborates with a team of specialists to provide comprehensive care, addressing all aspects of a patient's condition.
• Patient-Centered Care: Committed to providing personalized treatment plans tailored to the unique needs of each patient, ensuring the highest level of care and satisfaction.
• Continuous Education: Regularly attends national and international conferences and workshops, staying updated with the latest advancements in orthopedic surgery.

• Achievements and Recognition:
• Patient Satisfaction: Highly rated by patients for his expertise, professionalism, and compassionate care, with numerous positive reviews reflecting his dedication.
• Academic Contributions: Actively involved in teaching and mentoring medical students and residents, contributing to the advancement of orthopedic education.
• Professional Memberships: Member of several prestigious medical societies, reflecting his commitment to maintaining high standards in orthopedic practice.

Education:

Medical Degree: Çukurova University Faculty of Medicine (1993)

Specialization in Urology: Şişli Etfal Training and Research Hospital (2005)

Professional Experience:

Current Position: Practicing at İstinye University Hospital Medical Park Gaziosmanpaşa, Istanbul

Past Experience: Extensive work in both public and private healthcare sectors, including significant contributions at Istanbul İstinye University Health Practice and Research Center.

Areas of Interest:

Pediatric Urology

Urogynecology

Treatment of pediatric urology disorders

Urological surgeries and procedures

Professional Memberships:

Member of several prestigious medical societies, including the Turkish Medical Association, European Society of Pediatric Urology, and the Turkish Society of Pediatric Urology.

Certifications:

Dr. Güllüoğlu has completed numerous certifications and advanced training programs, reflecting his commitment to continuous professional development and staying at the forefront of urological advancements.

• AREAS OF INTEREST
• Abdominal lining cancers
• Gastric cancer
• Colon rectum cancer
• pancreatic cancer
• breast cancer diseases
• Thyroid cancer diseases
• Liver gallbladder surgery
• Laparoscopic cancer surgery

• Education
• 1993 Ondokuzmayıs University Faculty of Medicine
• 2000 Ankara University Faculty of Medicine Medical Specialization
• 2007 Ankara University Surgical Oncology Sub-branch Specialization

• Experience
• 1995-2000 Ankara University Faculty of Medicine Department of General Surgery Res.Asst.
• 2001-2002 Cumhuriyet University Faculty of Medicine Department of General Surgery Lecturer
• 2002-April 2004 Cumhuriyet University Faculty of Medicine Department of General Surgery Assoc. Prof.
• 2004- October 2007 Ankara University Faculty of Medicine, Surgical Oncology Subspecialty Training
• October 2006 Cumhuriyet University Faculty of Medicine, Department of General Surgery, Associate Professor
• January 2012 Cumhuriyet University Faculty of Medicine, Department of General Surgery, Professor

• Memberships in Scientific Organizations
• Surgical Oncology Association, Turkish Surgical Association
• Turkish Colon and Rectal Surgery Association
• National Vascular Surgery Association, Turkish Medical Association
• Refereeing in Scientific Journals
• Turkish Journal of Surgery
• Turkish Clinics Journal of Medical Sciences
• Cumhuriyet Medical Journal  
• Dicle Medical Journal

• Awards
• Best Research Award (E19)
• Surgical Oncology Congress (Istanbul, 2003)
• Poster 3rd Place Award (E7)
• Poster 1st Place Award (E51)
• Clinical Enteral Parenteral Nutrition
• Congress (Istanbul, 2000)
• TÜSAD (Çeşme 2012)
•  
•  
• Education and Training:
• Medical Degree: Graduated from Ankara University Faculty of Medicine.
• Specialization in General Surgery: Completed residency at Ankara University Faculty of Medicine from 1995 to 2000.
• Subspecialty in Surgical Oncology: Advanced training in Surgical Oncology at Ankara University from 2004 to 2007.

• Professional Experience:
• Academic Roles: Served as Assistant Professor and Associate Professor at Cumhuriyet University Faculty of Medicine, contributing significantly to medical education and research from 2001 to 2004.
• Current Position: Practicing at İstinye University Hospital Medical Park Gaziosmanpaşa, Istanbul, where he provides expert surgical oncology and general surgery services.

• Areas of Expertise:
• Cancer Surgery: Specializes in colorectal, gastric, pancreatic, and liver cancers, with extensive experience in managing complex oncological cases.
• General Surgery: Expertise in treating conditions such as gallstones, hernias, thyroid disorders, and gastrointestinal diseases.
• Advanced Surgical Techniques: Proficient in minimally invasive laparoscopic and robotic surgeries, ensuring better outcomes and quicker recovery for patients.

• Achievements and Recognition:
• Published Research: Authored numerous articles in prestigious medical journals, contributing to advancements in surgical oncology.
• Professional Awards: Recipient of the Best Research Award at the Surgical Oncology Congress in Istanbul (2003) and a Poster Award for his contributions to cancer research.

• Education and Specialization:
• Medical Degree: Ankara University Faculty of Medicine (1994)
• Specialization in Cardiovascular Surgery: Gazi University, Department of Cardiovascular Surgery

• Professional Experience:
• Former Experience: Cardiovascular Surgeon at Gazi University Hospital and SANKO University Hospital
• Current Position: Cardiovascular Surgeon at İstinye University Hospital Medical Park Gaziosmanpaşa

• Areas of Interest:
• Coronary Artery Diseases and Coronary Bypass
• Minimally Invasive Cardiac Surgery
• Peripheral Arterial Diseases
• Heart Valve Diseases and Minimally Invasive Valve Surgery
• Venous Diseases and Endovascular Interventions
• Aortic Surgery and Endovascular Aortic Interventions

• Research and Publications:
• Dr. Erdoğan has contributed significantly to cardiovascular research, with numerous publications in international and national peer-reviewed journals. His research covers topics like coronary artery disease, minimally invasive cardiac surgery, and endovascular interventions.

He entered Istanbul University Cerrahpaşa Faculty of Medicine in 1987 and started his compulsory service in Akçaabat district of Trabzon in 1993. In January 1995, he was admitted to the Hepato-Biliary Surgery service of the Universite Libre Bruxelles Erasmus Hospital in Brussels, Belgium. He started his General Surgery residency in October 1996 and became a General Surgery Specialist in Belgium in 2002 with the thesis "Le Re-do Gastroplastie dans le traitement des complications des Procedure Bariatriques pour Obesité Morbide" (Revision Surgery in the Treatment of Complications of Bariatric Procedures for Morbid Obesity).

He worked in the Hepatobiliary Surgery service of ULB Erasmus Hospital until October 2003, and then in October 2003 he joined Providence Hospital in Neuchatel, Switzerland as Deputy Chief of Surgery Clinic. In March 2004, he was appointed as Chief of Surgery Clinic at Neuchatel Hospital Cadolles Pourtales NHP and played an important role in Advanced Laparoscopic Surgery, Bariatric Surgery, Oncologic Surgery, Traumatology, Vascular and Thoracic Surgery and resident training.

He started his career in the private sector by obtaining equivalency in the field of General Surgery at Çukurova University. He is currently serving as a General Surgery Specialist at NPISTANBUL Hospital.

Areas of Interest:

• Obesity and Metabolic Surgery
• Laparoscopic Surgery
• Breast Surgery
• Proctology
• Goiter/Thyroid Surgery
• Colon and Cancer Surgery

• AREAS OF INTEREST
• Spine surgery
• Scoliosis
• Kyphosis
• Childhood spinal diseases
• Degenerative spine diseases
• Lumbar cervical disc herniation
• Knee hip joint disorders
• Orthopedic trauma surgery

• Education and Specialization
• 2010 - Cerrahpasa Faculty of Medicine - Medical Education
• 2016 - Medeniyet University Goztepe Training and Research Hospital - Specialization

• Experience
• 2016 - 2022 - Sisli Hamidiye Etfal Training and Research Hospital
• 2015 -2016 - Chicago Loyola University, Illinois, USA

• Courses and Certificates
• 13.12.2019-14.12.2019 Turkish Spine Society Eurospine Accredited Education Modules
• 08.11.2019-10.11.2019 Turkish Spine Society Eurospine Accredited Education Modules
• 31.08.2015-04.09.2015 Basic Microsurgery Course, MICROSURGERY EDUCATION-RESEARCH LABORATORY
• AO Trauma Course-Basic Principles of Fracture Management
• 07.06.2014-10.06.2014 Fracture Management, Kodi Kojima Chairperson AOTrauma Education Commission
• 01.03.2013-02.03.2013 Instrumentation in Arthroscopic Surgery

• Professional Memberships
• Turkish Orthopedics and Traumatology Association (TOTBİD)
• Turkish Medical Association - Istanbul Medical Chamber

uzmanlık

Medical Interests 

Interventional Bronchoscopy 

Respiratory Deficiencies 

Rare diseases of the lung 

Interstitial lung diseases 

Psychoneuroimmunology 

Medical Fitness and nutrition 

Education 

Bachelor’s: Istanbul University / Istanbul Faculty of Medicine / 1988-1997 

Specialization in Medicine: Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / Chest Diseases and Tuberculosis / 2001-2006 The Importance and Value of CA-125 in the Diagnosis of Tuberculosis Pleurisy / Assoc. Sedat Altın - Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital

Experience 

Dr. / Ayazağa MCHFP / 1997-2001 

Assist. Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / 2001-2006 

Res. See. / Hopital St-Marguerite Center Laser / 2004 

Res. See. / University de St-Etienne, Faculte de Medecin, Pneumologie et Oncologie Thoracique / 2005 

Dr. / Bozüyük State Hospital / 2006-2008 

Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Interventional Pulmonology Unit / 2008-2012 

Dr. / Zürich University Faculty of Medicine, Lung Transplantation Unit / 2009-2010 

Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Respiratory Intensive Care Unit / 2010-2012 

Assoc. Dr / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2013- 2017 

Prof. Dr. / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2017-2018 • prof. Dr. / Memorial Bahçelievler Hospital / 2018-2018 

Prof. Dr. Demiroglu Science Un. Faculty of Medicine Chest Diseases USA-Istanbul / 2018-2020 Florence Nightingale Hospital 

Prof. Dr. / Memorial Bahçelievler and Şişli Hospitals / 2020-2021 

Liv Hospital Vadistanbul / 2021 -

Memberships 

European Respiratory Society (ERS) 

European Association of Bronchology and Interventional Pulmonology (EABIP) 

Societé de Pnemologie de langue Française (SPLF) 

Groupe d’Endoscopie de langue française (GELF)

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Prof. Dr. Emre Şeker is a renowned dental specialist with a distinguished academic career and extensive clinical experience. As the founder of Dentarma Dental Clinic, he combines his expertise with a patient-centered approach to deliver exceptional dental care.

Prof. Dr. Şeker holds a Ph.D. in Prosthodontics and has served as an Associate Professor at esteemed universities in Turkey. His academic background, coupled with his hands-on clinical practice, positions him as a leading authority in the field of implant dentistry, smile design, and advanced prosthetic treatments.

With a focus on patient satisfaction and utilizing cutting-edge technology, Prof. Dr. Emre Şeker and his team at Dentarma are committed to providing world-class dental solutions.

Key Areas of Expertise:

• Implant dentistry
• Smile design
• Prosthetic dentistry
• Digital dentistry
• Aesthetic dentistry

Prof. Dr. Mustafa ÖZATEŞ

Dr Ozates was born in 1966 in Birecik district of Sanliurfa in Turkey. He completed his primary and secondary education in my hometown, Birecik. He got into Istanbul University Istanbul Faculty of Medicine in 1983. After 6 years of successful education, he started Radiology education at Dicle University Faculty of Medicine by passing the Medical Specialization Examination (TUS) in the same year I graduated in 1989.

Between 1993 and 1995, he worked as a Radiology Specialist in various hospitals in Gaziantep. He passed the Assistant Professorship exam and started to work as a faculty member at Dicle University in 1995.

Post-Specialization Trainings:

2003, Gazi University Faculty of Medicine, MRI Department, Ankara

2003, Marmara University Faculty of Medicine, MRI Department, Istanbul

2001-2004, ESNR European Course of Neuroradiology (3 Semesters)

1997, Johns Hopkins University, Neuroradiology, Baltimore, USA

1997, Cornell University, Neuroradiology, New York, USA

1996, Istanbul University Faculty of Medicine, MRI Department, Istanbul

1994, Dokuz Eylül University Faculty of Medicine, MRI Department, İzmir

1993, Uludağ University Faculty of Medicine, MRI Department, Bursa

1993, UCLA Medical Center (as visitor), Los Angles, USA

1992-1993, Maçka EMAR, Dr. Murat Dinçer, Istanbul

His Academic Studies:

International Publications: 23

International Papers: 27

National Publications: 45

National Papers: 48

Conferences: 11

Citations: 210 Scientific Publications (Average Citations per Item: 10.50, h-index: 9), USA edition 1 Book, Various Conferences

Scientific Organizations he is a member of:

European Society of Radiology (ESR)

Turkish Radiology Association (TRD)

Magnetic Resonance Association

Istanbul Medical Chamber (ITO)

Turkish Neuroradiology Association

In 2003, he was awarded the title of Associate Professor with the examination held at Marmara University Faculty of Medicine. In 2005-2013, Dr. Lütfi Kırdar Kartal Training and Research Hospital Radiology Clinic Chief, Training and Administrative Officer.

In 2013, he started to work as a professor at Nişantaşı University. On March 15, 2013, he was appointed as the Inter-University Board Representative for 1 year. He is a Member of the Board of Trustees of Ayvansaray University. He is a sub – specialist in “Pediatric Radiology”

His articles have been published in many magazines in Turkey and abroad. He presented written and oral presentations and gave conferences at congresses in various cities and countries.

As the Radiology Clinic Chief of Bağcılar Training and Research Hospital, he is the first professor who performed Coronary CT Angiography in a state hospital in Istanbul.

He is one of Turkey’s first Children’s Radiology Specialist Minor. He did his military service between March and April 2000 at the 200-bed Malatya Military Hospital.